SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-064687
Filing Date
2015-11-12
Accepted
2015-11-12 16:03:22
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v423256_10q.htm 10-Q 306825
2 EXHIBIT 31.1 v423256_ex31-1.htm EX-31.1 7717
3 EXHIBIT 31.2 v423256_ex31-2.htm EX-31.2 7718
4 EXHIBIT 32.1 v423256_ex32-1.htm EX-32.1 4859
  Complete submission text file 0001144204-15-064687.txt   3055313

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cpxx-20150930.xml EX-101.INS 663884
6 XBRL TAXONOMY EXTENSION SCHEMA cpxx-20150930.xsd EX-101.SCH 32034
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cpxx-20150930_cal.xml EX-101.CAL 35486
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cpxx-20150930_def.xml EX-101.DEF 171508
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cpxx-20150930_lab.xml EX-101.LAB 252628
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cpxx-20150930_pre.xml EX-101.PRE 211676
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36179 | Film No.: 151224222
SIC: 2834 Pharmaceutical Preparations